Tag Archives: funding

Proposal Development Support – SBIR/STTR

Posted on by
Reply

The Center for Biotechnology is offering one-on-one SBIR/STTR proposal development counseling and iterative grant writing services to companies – application for next cohort is June 5th!

Companies that have completed our intensive 2-day workshop (or similar program) and/or have previously submitted an unsuccessful SBIR/STTR proposal in the past are eligible to apply. Services provided under this program are awarded through a competitive application process and include a weekly “best practices” proposal development webinar followed by iterative review of section drafts to guide stepwise development of the proposal from start to finish.

Companies selected for this follow-on counseling will be required to contribute $250 and will receive up to 10 hours of iterative proposal development services valued at $2000. These services will be subsidized by the Center for Biotechnology through the Downstate New York SBIR Assistance Program.
Interested companies should apply online no later than June 5, 2020. The application can be found here: https://forms.gle/5m9kAN8nUnzEyXyi9.

Contact Kate Hutchinson kate.hutchinson@stonybrook.edu with questions.

Free Course from NIH: Entrepreneurial Finance for Biomedical Innovators

Posted on by
Reply

The course is presented in a series of five sequential videos. The video modules and course details can be found here: https://www.nibib.nih.gov/entrepreneurial-finance-course

The National Institutes of Health (NIH) supports the development and commercialization of biomedical technologies through the Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs. With the goal of bringing life-saving innovations to market, NIH SBIR/STTR funding provides early-stage seed capital to US-owned small businesses. While the commercialization of biomedical technologies can require a significant amount of both time and money, rigorous financial planning can help navigate and mitigate risks for small businesses and can enhance chances of success along the pathway to market. For biomedical innovators considering funding through the NIH SBIR/STTR programs (https://sbir.nih.gov), it is imperative to evaluate the use of federal grant funding within the context of a broader financial plan.

Course Objectives
The purpose of this course is to present biomedical entrepreneurs with a detailed framework for building a step-wise, validated financial plan. Moving beyond the short-term perspective of immediate financing needs to a comprehensive, long-term financial plan will increase the probability of success for your venture. The primary learning objectives for this course are as follows:

– Understand the importance of financial planning for your small business
– Gain perspective on SBIR/STTR funding within the broader context of your financial plan
– Learn practical approaches to developing a long-term financial plan
– Evaluate the various sources of funding
– Examine the use of comparables in validating your financial plan

 

Funding Opportunity: BARDA DRIVe EZ-BAA

Posted on by
Reply

As a BARDA DRIVe Accelerator, the Center for Biotechnology is pleased to announce that the simplified funding application process, called EZ BAA, is now open. Medical product developers, research teams, and companies offering disruptive solutions to health security threats are invited to submit abstracts beginning today using this simplified EZ BAA process.

Applications accepted through this streamlined process must offer transformative innovation, products and technologies to protect Americans from health security threats. This application process is a business friendly simple abstract.

In-scope priority areas include products and solutions to reduce illness and death from sepsis as part of DRIVe’s Solving Sepsis initiative; technologies and processes to identify infections and exposures to biological and other health threats, as outlined in the Early Notification to Act, Control, and Treat (ENACT) initiative; and tools and techniques to mitigate the damages and loss of life associated with catastrophic events.

Applying is simple:

  • Download the application form the DRIVe website.
  • Submit a technical abstract no longer than a 2,000 words
  • Include a cost proposal of an additional 2,000 words or less.
  • Proposed costs should not exceed $749,000.

What happens next:

  • Once submitted, DRIVe’s experts will review the application to ensure it is within scope and meets DRIVe criteria.
  • As the applicant, you’ll be notified of the review results within 30 days of your submission.

**The Center for Biotechnology is interested in working with potential applicants to help ensure the submission of a robust on-target proposal. If you are interested learning about how the Center for Biotechnology can help, please contact William Hanes: william.hanes@stonybrook.edu***

Learn more about the DRIVe EZ-BAA review criteria here.
Have questions? Looking more information? Contact DRIVeContracting@hhs.gov

Important SBIR/STTR Information Update from NIH

Posted on by
Reply

Update courtesy of BBC Entrepreneurial Training and Consulting

NIH is strongly encouraging small businesses to contact the appropriate Institute or Center early in their application planning to ensure their technology is a priority for the Institute/Center.

An updated SBIR/STTR Application Guide with additional instructions for SBIR Direct Phase II application preparation and submission will be posted by November 26, 2018. The following sections of each FOA are changed:

Part 2, Section I. Funding Opportunity Description The following has been added at the end of the section for each FOA:

PA-18-573 The following Components will not accept an SBIR Direct-to-Phase II submission:
– National Institute of Nursing Research (NINR)
– National Center for Complementary and Integrative Health (NCCIH)

PA-18-574 The following Components will not accept an SBIR Direct-to-Phase II submission:
– National Institute of Environmental Health Sciences (NIEHS )
– National Institute of Nursing Research (NINR)
– National Center for Complementary and Integrative Health (NCCIH)
– Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs (ORIP)
– Centers for Disease Control and Prevention (CDC) (All Components of CDC)
– U.S. Food and Drug Administration (FDA) (All Components of FDA)

Part 2, Section II. Award Information for both PA-18-573 and PA-18-574. Application types now allowed are:
– New (Phase I, Fast-Track)
– New (Direct Phase II)
– Renewal (Phase II)
– Resubmission (all phases)
– Phase IIB Competing Renewal (Phase IIB)
– Revision

The OER Glossary and the SF424 (R&R) SBIR/STTR Application Guide provide details on these application types.

LIBH Innovator Awarded Alexandria LaunchLabs Seed Capital Prize

Posted on by
Reply

Cold Spring Harbor Laboratory’s Alex Vaughan was awarded the 2018 Alexandria LaunchLabs Seed Capital Prize for the CSHL spinoff company MapNeuro Inc. during the NYC Life Science Innovation Showcase, held in New York City on June 14, 2018. Valued at $100,000, the prize, meant to fund early-stage development companies, includes a scholarship to Alexandria LaunchLabs, a cash award, and an investment from the Alexandria Seed Capital Platform, an innovative funding model catalyzing seed-stage life science investment.

MapNeuro Inc. commercializes “molecular connectomics” technology developed in the laboratory of CSHL Professor Anthony Zador. MapNeuro uses this platform to understand brain-wide patterns of neuronal connectivity, and is specifically targeting neurodegenerative diseases such as Parkinson’s Disease and Alzheimer’s Disease.

Read the full article here.